[{"indications": "Indications\u00a0see under Dose", "name": "FAMCICLOVIR", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.2 Herpesvirus infections", "5.3.2.1 Herpes simplex and varicella\u2013zoster infection", "FAMCICLOVIR"], "cautions": "Cautions\u00a0interactions: Appendix 1 (famciclovir)", "side-effects": "Side-effects\u00a0nausea, vomiting, abdominal pain, diarrhoea; headache,\r\nfatigue; sweating, pruritus; rarely confusion; very rarely jaundice, dizziness, drowsiness, hallucinations,\r\nthrombocytopenia, rash (including Stevens-Johnson syndrome); also\r\nreported, constipation and fever", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/14828.htm", "doses": ["Herpes zoster, treatment, 500\u00a0mg 3 times daily for 7 days or 750\u00a0mg 1\u20132 times daily for 7 days (in immunocompromised,\r\n500\u00a0mg 3 times daily for 10 days, continue for 2 days\r\nafter crusting of lesions)", "Genital herpes, treatment of first episode,\r\n250\u00a0mg 3 times daily for 5 days, longer if new lesions appear during\r\ntreatment or if healing incomplete (500\u00a0mg twice daily for 10 days\r\nin immunocompromised or HIV-positive patients); treatment of recurrent infection, 125\u00a0mg twice daily for 5 days or 1\u00a0g twice daily for 1 day (500\u00a0mg twice daily for 5\u201310\r\ndays in immunocompromised or HIV-positive patients)", "Genital herpes, suppression, 250\u00a0mg twice daily (500\u00a0mg twice\r\ndaily in immunocompromised or HIV-positive patients); therapy interrupted\r\nevery 6\u201312 months to reassess recurrence frequency\u2014consider restarting\r\nafter two or more recurrences", "Non-genital herpes simplex, treatment in the immunocompromised,\r\n500\u00a0mg twice daily for 7 days", "child not recommended", "Famciclovir doses in BNF may differ from\r\nthose in product literature"], "pregnancy": "Pregnancy\u00a0manufacturers advise avoid unless potential benefit\r\noutweighs risk"}]